ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,228Medicare Part D Prescriptions Filled, Including Refills

Rank: 506 out of 3001

$434K Total Retail Price of All Prescriptions

Rank: 820 out of 3001

372 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 372 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 372 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,693 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LISINOPRIL 544 438 1 2
SIMVASTATIN 354 287 2 1
PRAVASTATIN SODIUM 317 224 3 13
LEVOTHYROXINE SODIUM 292 219 4 3
FUROSEMIDE 263 213 5 6
OMEPRAZOLE 253 143 6 4
HYDROCODONE-ACETAMINOPHEN 251 196 S3 7 7
AMLODIPINE BESYLATE 248 175 8 5
METFORMIN HCL 233 142 9 9
HYDROCHLOROTHIAZIDE 190 99 10 10
ZOLPIDEM TARTRATE 182 140 11 24
WARFARIN SODIUM 148 129 12 12
LOSARTAN POTASSIUM 140 103 13 21
MIRTAZAPINE 133 105 14 44
CARVEDILOL 128 96 15 25
ATENOLOL 122 74 16 18
GLYBURIDE 116 87 R 17 62
METOPROLOL TARTRATE 115 93 18 8
AZITHROMYCIN 109 76 19 36
SERTRALINE HCL 98 56 20 20
TAMSULOSIN HCL 97 86 21 29
NEXIUM 97 40 21 23
DONEPEZIL HCL 96 96 23 27
MELOXICAM 91 79 24 34
CITALOPRAM HBR 89 35 25 16
OXYCODONE-ACETAMINOPHEN 88 72 S2 26 32
RANITIDINE HCL 87 48 27 41
ATORVASTATIN CALCIUM 83 67 28 11
GABAPENTIN 79 40 29 14
ALENDRONATE SODIUM 73 43 30 26
TRAZODONE HCL 71 59 31 37
PREDNISONE 70 54 32 39
CLOPIDOGREL 68 61 33 28
VERAPAMIL ER 65 40 34 102
PANTOPRAZOLE SODIUM 63 47 35 43
JANUVIA 62 35 36 54
OLANZAPINE 62 34 36 106
POTASSIUM CHLORIDE 62 28 36 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 42 36 22
VENLAFAXINE HCL ER 61 54 40 103
TIZANIDINE HCL 57 15 41 101
ENALAPRIL MALEATE 54 35 42 83
GEMFIBROZIL 53 37 43 117
TRAMADOL HCL 52 48 44 17
AMOXICILLIN 51 43 45 107
DIGOXIN 51 51 45 65
FLUTICASONE PROPIONATE 51 42 45 42
ALLOPURINOL 50 50 48 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 29, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.